Structured evidence table for Hesperetin Cardiometabolic Markers Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Hesperetin Cardiometabolic Markers Randomized Trial | 1 2 3 4 5 6 7 8 9 Epidemiological studies and meta-analyses have associated the intake of flavonoid-rich citrus fruit consumption with lower stroke risk [] and the incidence of some types of cancer [,]. | 4 | Ávila-Gálvez María Ángeles (2021) | New Insights into the Metabolism of the Flavanones Eriocitrin and Hesperidin: A Comparative Human Pharmacokinetic Study |
| Hesperetin Cardiometabolic Markers Randomized Trial | There is abundant evidence that reports the bioavailability, metabolism, and health-beneficial effects of hesperidin after hesperidin-rich sources intake in both animals and humans [,,,,]. | 4 | Ávila-Gálvez María Ángeles (2021) | New Insights into the Metabolism of the Flavanones Eriocitrin and Hesperidin: A Comparative Human Pharmacokinetic Study |
| Hesperetin Cardiometabolic Markers Randomized Trial | 10 11 There is evidence supporting that citrus flavonoids may represent promising bioactive agents for treating metabolic and cardiovascular diseases [,]. | 4 | Ávila-Gálvez María Ángeles (2021) | New Insights into the Metabolism of the Flavanones Eriocitrin and Hesperidin: A Comparative Human Pharmacokinetic Study |
| Hesperetin Cardiometabolic Markers Randomized Trial | Hesperidin and eriocitrin are the main flavonoids (flavanones) present in citrus, such as orange and lemon, respectively. | 4 | Ávila-Gálvez María Ángeles (2021) | New Insights into the Metabolism of the Flavanones Eriocitrin and Hesperidin: A Comparative Human Pharmacokinetic Study |
Source documents